Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pneumonectomy | 37 | 2024 | 1119 | 4.580 |
Why?
|
Tracheal Neoplasms | 16 | 2021 | 123 | 3.420 |
Why?
|
Thoracic Surgical Procedures | 10 | 2019 | 350 | 2.550 |
Why?
|
Esophagectomy | 19 | 2022 | 468 | 1.990 |
Why?
|
Lung Neoplasms | 38 | 2024 | 13382 | 1.880 |
Why?
|
Thoracic Surgery | 11 | 2019 | 722 | 1.630 |
Why?
|
Tracheal Stenosis | 7 | 2021 | 228 | 1.240 |
Why?
|
Esophageal Neoplasms | 16 | 2022 | 1654 | 1.230 |
Why?
|
Thoracic Surgery, Video-Assisted | 9 | 2023 | 285 | 1.190 |
Why?
|
Societies, Medical | 14 | 2019 | 3905 | 1.100 |
Why?
|
Respiratory Paralysis | 2 | 2016 | 32 | 1.090 |
Why?
|
Recurrent Laryngeal Nerve | 2 | 2016 | 143 | 0.990 |
Why?
|
Diaphragm | 2 | 2016 | 351 | 0.970 |
Why?
|
Postoperative Complications | 31 | 2024 | 15633 | 0.910 |
Why?
|
Thymectomy | 2 | 2015 | 195 | 0.900 |
Why?
|
Thoracic Wall | 3 | 2019 | 202 | 0.890 |
Why?
|
Mediastinal Neoplasms | 4 | 2018 | 401 | 0.860 |
Why?
|
Solitary Pulmonary Nodule | 3 | 2020 | 278 | 0.800 |
Why?
|
Laryngeal Neoplasms | 5 | 2010 | 514 | 0.790 |
Why?
|
Tracheal Diseases | 5 | 2007 | 118 | 0.750 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 9 | 2022 | 5315 | 0.730 |
Why?
|
Databases, Factual | 17 | 2021 | 7967 | 0.710 |
Why?
|
Respiration | 2 | 2016 | 1657 | 0.690 |
Why?
|
Biomedical Research | 4 | 2019 | 3429 | 0.680 |
Why?
|
Tracheostomy | 2 | 2021 | 426 | 0.640 |
Why?
|
Intubation, Intratracheal | 6 | 2021 | 1333 | 0.640 |
Why?
|
Laryngectomy | 4 | 2010 | 243 | 0.640 |
Why?
|
Trachea | 8 | 2012 | 1089 | 0.560 |
Why?
|
Carcinoma, Adenoid Cystic | 6 | 2019 | 262 | 0.550 |
Why?
|
Postoperative Hemorrhage | 1 | 2020 | 415 | 0.530 |
Why?
|
Bronchial Neoplasms | 5 | 2006 | 110 | 0.510 |
Why?
|
Neoplasm Staging | 16 | 2022 | 11121 | 0.490 |
Why?
|
Tracheoesophageal Fistula | 3 | 2018 | 131 | 0.460 |
Why?
|
Pleural Neoplasms | 4 | 2020 | 609 | 0.460 |
Why?
|
Esophagus | 8 | 2012 | 1033 | 0.440 |
Why?
|
Retrospective Studies | 54 | 2024 | 80646 | 0.430 |
Why?
|
Registries | 5 | 2024 | 8224 | 0.430 |
Why?
|
Anemia, Hemolytic | 1 | 2014 | 162 | 0.430 |
Why?
|
Pneumonia | 2 | 2023 | 2143 | 0.420 |
Why?
|
Anastomosis, Surgical | 10 | 2021 | 983 | 0.420 |
Why?
|
Pulmonary Veno-Occlusive Disease | 2 | 2013 | 64 | 0.420 |
Why?
|
Idiopathic Pulmonary Fibrosis | 3 | 2024 | 515 | 0.410 |
Why?
|
Bronchoscopy | 6 | 2024 | 909 | 0.410 |
Why?
|
Angiography | 1 | 2018 | 1595 | 0.410 |
Why?
|
Muscle, Skeletal | 4 | 2020 | 4948 | 0.380 |
Why?
|
Myasthenia Gravis | 1 | 2014 | 214 | 0.380 |
Why?
|
Neoadjuvant Therapy | 7 | 2019 | 2827 | 0.380 |
Why?
|
Bronchial Diseases | 3 | 2005 | 150 | 0.370 |
Why?
|
Pulmonary Artery | 1 | 2019 | 1927 | 0.360 |
Why?
|
Humans | 138 | 2024 | 761572 | 0.350 |
Why?
|
Airway Obstruction | 5 | 2010 | 661 | 0.350 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2014 | 592 | 0.350 |
Why?
|
Esophagitis | 3 | 2003 | 164 | 0.350 |
Why?
|
Carcinoma, Squamous Cell | 11 | 2019 | 4026 | 0.340 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2014 | 664 | 0.330 |
Why?
|
Deglutition Disorders | 5 | 2017 | 625 | 0.320 |
Why?
|
Esophageal Diseases | 4 | 2008 | 168 | 0.310 |
Why?
|
Treatment Outcome | 36 | 2022 | 64684 | 0.300 |
Why?
|
Respiratory Tract Fistula | 1 | 2007 | 25 | 0.290 |
Why?
|
Male | 93 | 2024 | 360842 | 0.290 |
Why?
|
Patient Selection | 4 | 2019 | 4244 | 0.290 |
Why?
|
Middle Aged | 76 | 2024 | 220920 | 0.290 |
Why?
|
Aged | 69 | 2024 | 169310 | 0.290 |
Why?
|
Granular Cell Tumor | 1 | 2007 | 48 | 0.280 |
Why?
|
Esophageal Perforation | 3 | 2022 | 65 | 0.280 |
Why?
|
Survival Rate | 17 | 2021 | 12725 | 0.280 |
Why?
|
Cutaneous Fistula | 1 | 2007 | 79 | 0.280 |
Why?
|
Reoperation | 7 | 2021 | 4303 | 0.280 |
Why?
|
Thyroidectomy | 2 | 2010 | 908 | 0.280 |
Why?
|
Quality Improvement | 7 | 2019 | 3801 | 0.280 |
Why?
|
Female | 90 | 2024 | 392686 | 0.270 |
Why?
|
Bronchi | 3 | 2019 | 845 | 0.260 |
Why?
|
Sarcopenia | 2 | 2021 | 372 | 0.250 |
Why?
|
Tomography, Optical Coherence | 3 | 2024 | 2917 | 0.250 |
Why?
|
Advisory Committees | 3 | 2018 | 787 | 0.250 |
Why?
|
Thyroid Neoplasms | 2 | 2010 | 2332 | 0.250 |
Why?
|
Esophageal Achalasia | 1 | 2006 | 94 | 0.250 |
Why?
|
Gastric Emptying | 2 | 2021 | 242 | 0.240 |
Why?
|
Diverticulum | 1 | 2006 | 137 | 0.240 |
Why?
|
Pleura | 2 | 2020 | 245 | 0.240 |
Why?
|
Survival Analysis | 10 | 2021 | 10090 | 0.230 |
Why?
|
Thoracic Neoplasms | 1 | 2006 | 267 | 0.220 |
Why?
|
Thoracotomy | 5 | 2017 | 367 | 0.220 |
Why?
|
Mesothelioma | 1 | 2009 | 807 | 0.210 |
Why?
|
Lymph Node Excision | 3 | 2022 | 1271 | 0.200 |
Why?
|
Neoplasms, Glandular and Epithelial | 1 | 2006 | 487 | 0.200 |
Why?
|
Stents | 4 | 2022 | 3179 | 0.200 |
Why?
|
Bronchial Fistula | 2 | 2018 | 83 | 0.200 |
Why?
|
Intussusception | 1 | 2003 | 115 | 0.200 |
Why?
|
Pulmonary Emphysema | 3 | 1996 | 684 | 0.200 |
Why?
|
Adenocarcinoma | 11 | 2019 | 6346 | 0.190 |
Why?
|
Gastroesophageal Reflux | 3 | 2006 | 819 | 0.190 |
Why?
|
Esophageal Stenosis | 3 | 2009 | 196 | 0.190 |
Why?
|
Barrett Esophagus | 3 | 2011 | 492 | 0.190 |
Why?
|
Jejunum | 2 | 1993 | 472 | 0.180 |
Why?
|
Neoplasm Recurrence, Local | 10 | 2019 | 9280 | 0.180 |
Why?
|
Internship and Residency | 1 | 2021 | 5882 | 0.180 |
Why?
|
Oxygen Inhalation Therapy | 1 | 2024 | 411 | 0.180 |
Why?
|
Tomography, X-Ray Computed | 11 | 2022 | 20571 | 0.180 |
Why?
|
Pulmonary Surgical Procedures | 1 | 2020 | 34 | 0.180 |
Why?
|
Calcinosis | 1 | 2009 | 1469 | 0.180 |
Why?
|
Follow-Up Studies | 14 | 2021 | 39107 | 0.180 |
Why?
|
Laryngostenosis | 2 | 2010 | 167 | 0.170 |
Why?
|
Solitary Fibrous Tumors | 1 | 2020 | 67 | 0.170 |
Why?
|
Catheter Ablation | 2 | 2013 | 2751 | 0.170 |
Why?
|
Colon | 3 | 2008 | 1792 | 0.160 |
Why?
|
Adult | 45 | 2021 | 221203 | 0.160 |
Why?
|
Radiotherapy, Adjuvant | 4 | 2010 | 1784 | 0.160 |
Why?
|
Respiration Disorders | 1 | 2022 | 367 | 0.160 |
Why?
|
Gastric Outlet Obstruction | 2 | 2011 | 54 | 0.160 |
Why?
|
Pylorus | 2 | 2011 | 86 | 0.160 |
Why?
|
Education, Medical, Graduate | 2 | 2021 | 2373 | 0.160 |
Why?
|
Acute Kidney Injury | 1 | 2011 | 1924 | 0.160 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2006 | 1374 | 0.160 |
Why?
|
Foramen Ovale, Patent | 1 | 2021 | 208 | 0.150 |
Why?
|
Lung Diseases | 2 | 2009 | 1909 | 0.150 |
Why?
|
Stomach | 2 | 2021 | 696 | 0.150 |
Why?
|
Preoperative Care | 2 | 2018 | 2242 | 0.150 |
Why?
|
Lung | 8 | 2024 | 10002 | 0.150 |
Why?
|
RNA, Neoplasm | 1 | 2020 | 750 | 0.150 |
Why?
|
Diverticulum, Esophageal | 1 | 2017 | 14 | 0.150 |
Why?
|
Thoracoscopy | 2 | 2017 | 181 | 0.150 |
Why?
|
United States | 18 | 2024 | 72335 | 0.140 |
Why?
|
Physician's Role | 1 | 2004 | 917 | 0.140 |
Why?
|
Biopsy | 2 | 2020 | 6766 | 0.140 |
Why?
|
Massachusetts | 4 | 2021 | 8830 | 0.130 |
Why?
|
Forecasting | 2 | 2017 | 2928 | 0.130 |
Why?
|
Candidiasis | 1 | 1999 | 365 | 0.130 |
Why?
|
Catheterization | 3 | 2011 | 1428 | 0.130 |
Why?
|
Neoplasm Invasiveness | 6 | 2020 | 3597 | 0.130 |
Why?
|
Neuromuscular Blockade | 1 | 2016 | 147 | 0.130 |
Why?
|
Risk Factors | 15 | 2024 | 74213 | 0.120 |
Why?
|
Incidence | 5 | 2024 | 21355 | 0.120 |
Why?
|
Databases as Topic | 1 | 2017 | 473 | 0.120 |
Why?
|
Combined Modality Therapy | 7 | 2009 | 8528 | 0.120 |
Why?
|
Aged, 80 and over | 23 | 2022 | 58986 | 0.120 |
Why?
|
Thoracic Diseases | 1 | 2016 | 99 | 0.120 |
Why?
|
Immunity, Cellular | 1 | 2020 | 1560 | 0.120 |
Why?
|
Necrosis | 4 | 2003 | 1611 | 0.120 |
Why?
|
Hospital Mortality | 5 | 2012 | 5293 | 0.120 |
Why?
|
Ischemia | 1 | 2003 | 1883 | 0.120 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2016 | 321 | 0.120 |
Why?
|
Consensus | 2 | 2021 | 3123 | 0.110 |
Why?
|
Neoplasm Metastasis | 3 | 2019 | 4915 | 0.110 |
Why?
|
Lymph Nodes | 2 | 2022 | 3466 | 0.110 |
Why?
|
Length of Stay | 4 | 2020 | 6426 | 0.110 |
Why?
|
Burns, Inhalation | 1 | 1993 | 35 | 0.110 |
Why?
|
Body Composition | 2 | 2020 | 2426 | 0.110 |
Why?
|
Muscle Weakness | 1 | 2016 | 412 | 0.110 |
Why?
|
Plasma Cell Granuloma, Pulmonary | 1 | 2013 | 12 | 0.110 |
Why?
|
Forced Expiratory Volume | 5 | 2019 | 1814 | 0.110 |
Why?
|
Dyspnea | 4 | 2012 | 1347 | 0.110 |
Why?
|
Esophagogastric Junction | 2 | 2016 | 347 | 0.110 |
Why?
|
Pulmonary Aspergillosis | 1 | 2013 | 47 | 0.110 |
Why?
|
Solitary Fibrous Tumor, Pleural | 1 | 2012 | 25 | 0.110 |
Why?
|
Clinical Trials as Topic | 3 | 2011 | 8002 | 0.110 |
Why?
|
Amyloidosis | 1 | 2020 | 817 | 0.110 |
Why?
|
Hospital Costs | 1 | 2018 | 947 | 0.100 |
Why?
|
Muscle Strength | 1 | 2016 | 624 | 0.100 |
Why?
|
Esophageal Fistula | 2 | 2003 | 60 | 0.100 |
Why?
|
Muscular Diseases | 1 | 2016 | 553 | 0.100 |
Why?
|
Carcinoma, Mucoepidermoid | 2 | 2019 | 89 | 0.100 |
Why?
|
Risk Assessment | 9 | 2024 | 23996 | 0.100 |
Why?
|
Cardiac Surgical Procedures | 2 | 2018 | 3627 | 0.100 |
Why?
|
Fundoplication | 2 | 2017 | 144 | 0.100 |
Why?
|
Atrial Fibrillation | 2 | 2013 | 5127 | 0.090 |
Why?
|
Esophagoscopy | 2 | 2011 | 396 | 0.090 |
Why?
|
Silicones | 1 | 2012 | 228 | 0.090 |
Why?
|
Venous Thromboembolism | 1 | 2024 | 1866 | 0.090 |
Why?
|
Benchmarking | 1 | 2017 | 1045 | 0.090 |
Why?
|
Computer Simulation | 2 | 2021 | 6241 | 0.090 |
Why?
|
Tracheomalacia | 1 | 2010 | 63 | 0.090 |
Why?
|
Research | 1 | 2018 | 1982 | 0.090 |
Why?
|
Pleurodesis | 1 | 2010 | 46 | 0.080 |
Why?
|
Risk Adjustment | 2 | 2017 | 600 | 0.080 |
Why?
|
General Surgery | 1 | 2021 | 1692 | 0.080 |
Why?
|
Pulmonary Diffusing Capacity | 1 | 2009 | 94 | 0.080 |
Why?
|
Echocardiography, Transesophageal | 2 | 2021 | 1086 | 0.080 |
Why?
|
Cough | 3 | 2012 | 594 | 0.080 |
Why?
|
Mediastinal Diseases | 1 | 2009 | 91 | 0.080 |
Why?
|
Vena Cava, Superior | 1 | 2009 | 195 | 0.080 |
Why?
|
Respiratory Insufficiency | 1 | 2017 | 1230 | 0.080 |
Why?
|
Lung Diseases, Interstitial | 1 | 2017 | 918 | 0.080 |
Why?
|
Esophagoplasty | 1 | 2008 | 48 | 0.080 |
Why?
|
Hemoptysis | 2 | 2010 | 152 | 0.080 |
Why?
|
Pleural Diseases | 1 | 2009 | 137 | 0.080 |
Why?
|
Embolization, Therapeutic | 1 | 2018 | 1418 | 0.070 |
Why?
|
Adipose Tissue | 1 | 2020 | 3312 | 0.070 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2020 | 8552 | 0.070 |
Why?
|
Sarcoma | 2 | 2011 | 1801 | 0.070 |
Why?
|
Microsatellite Instability | 1 | 2011 | 716 | 0.070 |
Why?
|
Medical Audit | 1 | 2008 | 453 | 0.070 |
Why?
|
Lymphangiosarcoma | 1 | 2006 | 14 | 0.070 |
Why?
|
Fatal Outcome | 2 | 2009 | 1835 | 0.070 |
Why?
|
Patient Readmission | 1 | 2021 | 3271 | 0.070 |
Why?
|
Osteolysis, Essential | 1 | 2006 | 30 | 0.070 |
Why?
|
Quality Assurance, Health Care | 1 | 2017 | 2169 | 0.070 |
Why?
|
Gastric Fistula | 1 | 2007 | 73 | 0.070 |
Why?
|
Kaplan-Meier Estimate | 5 | 2019 | 6484 | 0.070 |
Why?
|
Clinical Competence | 2 | 2020 | 4793 | 0.070 |
Why?
|
Lung Transplantation | 1 | 1996 | 1310 | 0.070 |
Why?
|
Life Tables | 1 | 2006 | 364 | 0.070 |
Why?
|
Lymphatic Metastasis | 3 | 2015 | 2915 | 0.060 |
Why?
|
Proto-Oncogene Proteins c-sis | 1 | 2006 | 255 | 0.060 |
Why?
|
Time Factors | 8 | 2019 | 39970 | 0.060 |
Why?
|
Adolescent | 14 | 2019 | 88324 | 0.060 |
Why?
|
Reproducibility of Results | 2 | 2020 | 20099 | 0.060 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2019 | 4580 | 0.060 |
Why?
|
Respiratory Sounds | 2 | 2010 | 702 | 0.060 |
Why?
|
Radionuclide Imaging | 1 | 2009 | 1972 | 0.060 |
Why?
|
Hoarseness | 1 | 2005 | 63 | 0.060 |
Why?
|
Child | 12 | 2019 | 80156 | 0.060 |
Why?
|
Recurrence | 2 | 2009 | 8466 | 0.060 |
Why?
|
Body Mass Index | 2 | 2019 | 12954 | 0.060 |
Why?
|
Laryngoscopy | 1 | 2010 | 707 | 0.060 |
Why?
|
Severity of Illness Index | 3 | 2017 | 15843 | 0.060 |
Why?
|
Thymoma | 1 | 2005 | 188 | 0.060 |
Why?
|
Tracheotomy | 1 | 2004 | 167 | 0.060 |
Why?
|
Myocardial Perfusion Imaging | 1 | 2009 | 575 | 0.050 |
Why?
|
Surgical Wound Dehiscence | 1 | 2004 | 212 | 0.050 |
Why?
|
Prognosis | 8 | 2020 | 29629 | 0.050 |
Why?
|
Pulmonary Veins | 1 | 2009 | 743 | 0.050 |
Why?
|
Thymus Neoplasms | 1 | 2005 | 274 | 0.050 |
Why?
|
Salivary Gland Neoplasms | 1 | 2006 | 304 | 0.050 |
Why?
|
Chondrosarcoma | 1 | 2005 | 296 | 0.050 |
Why?
|
Morbidity | 2 | 2019 | 1750 | 0.050 |
Why?
|
Stomach Neoplasms | 2 | 2011 | 1459 | 0.050 |
Why?
|
Prospective Studies | 4 | 2021 | 54426 | 0.050 |
Why?
|
Muscle, Smooth | 1 | 2006 | 926 | 0.050 |
Why?
|
Chest Pain | 1 | 2009 | 1091 | 0.050 |
Why?
|
Immunohistochemistry | 6 | 2020 | 11076 | 0.050 |
Why?
|
Early Detection of Cancer | 3 | 2022 | 3201 | 0.050 |
Why?
|
Diagnostic Errors | 1 | 2009 | 1265 | 0.050 |
Why?
|
Device Removal | 1 | 2006 | 630 | 0.050 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2010 | 3514 | 0.050 |
Why?
|
beta-Galactosidase | 2 | 1999 | 574 | 0.050 |
Why?
|
Radiography | 3 | 2009 | 6965 | 0.050 |
Why?
|
Anastomotic Leak | 1 | 2022 | 163 | 0.050 |
Why?
|
Equipment Design | 2 | 2003 | 3511 | 0.050 |
Why?
|
Child, Preschool | 6 | 2019 | 42230 | 0.050 |
Why?
|
Neoplasms, Fibrous Tissue | 1 | 2001 | 20 | 0.050 |
Why?
|
Multivariate Analysis | 3 | 2015 | 12059 | 0.050 |
Why?
|
Hospitals, General | 2 | 2017 | 798 | 0.040 |
Why?
|
Papillomaviridae | 2 | 1999 | 1119 | 0.040 |
Why?
|
Respiratory Function Tests | 3 | 2010 | 1682 | 0.040 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 3 | 2016 | 11742 | 0.040 |
Why?
|
Leiomyoma | 1 | 2005 | 636 | 0.040 |
Why?
|
Disease-Free Survival | 3 | 2016 | 6815 | 0.040 |
Why?
|
Cohort Studies | 7 | 2020 | 41493 | 0.040 |
Why?
|
Odds Ratio | 2 | 2009 | 9646 | 0.040 |
Why?
|
Larynx | 1 | 2004 | 492 | 0.040 |
Why?
|
Positive-Pressure Respiration | 1 | 2024 | 639 | 0.040 |
Why?
|
Perioperative Period | 1 | 2021 | 250 | 0.040 |
Why?
|
Otorhinolaryngologic Surgical Procedures | 1 | 2003 | 324 | 0.040 |
Why?
|
Constriction, Pathologic | 1 | 2003 | 1096 | 0.040 |
Why?
|
Diagnosis, Differential | 2 | 2020 | 12975 | 0.040 |
Why?
|
Education, Medical, Continuing | 2 | 2017 | 823 | 0.040 |
Why?
|
Papain | 1 | 1999 | 65 | 0.040 |
Why?
|
Chymotrypsin | 1 | 1999 | 138 | 0.040 |
Why?
|
Palliative Care | 2 | 2006 | 3598 | 0.040 |
Why?
|
Preoperative Period | 1 | 2021 | 551 | 0.040 |
Why?
|
Annual Reports as Topic | 1 | 2018 | 36 | 0.040 |
Why?
|
Cocarcinogenesis | 3 | 1987 | 49 | 0.040 |
Why?
|
Oxygen | 2 | 2024 | 4227 | 0.040 |
Why?
|
Digestive System Neoplasms | 1 | 1999 | 82 | 0.040 |
Why?
|
Heart Defects, Congenital | 1 | 2015 | 4671 | 0.040 |
Why?
|
Surgical Procedures, Operative | 2 | 2004 | 1924 | 0.040 |
Why?
|
Mentors | 1 | 2004 | 661 | 0.040 |
Why?
|
Neurilemmoma | 1 | 2003 | 526 | 0.040 |
Why?
|
Logistic Models | 2 | 2021 | 13255 | 0.040 |
Why?
|
Shoulder Fractures | 1 | 1999 | 93 | 0.040 |
Why?
|
Liposarcoma | 1 | 2001 | 289 | 0.040 |
Why?
|
Shoulder Dislocation | 1 | 1999 | 129 | 0.040 |
Why?
|
Immunocompromised Host | 1 | 2003 | 857 | 0.040 |
Why?
|
Patient Care Team | 1 | 2008 | 2521 | 0.040 |
Why?
|
Hair Follicle | 1 | 1999 | 211 | 0.040 |
Why?
|
Epidermal Growth Factor | 3 | 1998 | 702 | 0.040 |
Why?
|
Foreign-Body Migration | 1 | 1999 | 219 | 0.040 |
Why?
|
Humerus | 1 | 1999 | 272 | 0.040 |
Why?
|
Carcinogens | 3 | 1989 | 452 | 0.040 |
Why?
|
Radiation-Sensitizing Agents | 1 | 1999 | 350 | 0.030 |
Why?
|
Genotype | 1 | 2011 | 12990 | 0.030 |
Why?
|
Oncogene Proteins, Viral | 1 | 1998 | 340 | 0.030 |
Why?
|
Radiotherapy | 1 | 2003 | 1499 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 3 | 2016 | 36429 | 0.030 |
Why?
|
Thorax | 1 | 1999 | 555 | 0.030 |
Why?
|
Anorexia | 1 | 2016 | 154 | 0.030 |
Why?
|
Total Lung Capacity | 1 | 1996 | 149 | 0.030 |
Why?
|
Organizational Innovation | 1 | 2018 | 537 | 0.030 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 1999 | 621 | 0.030 |
Why?
|
Paclitaxel | 2 | 2001 | 1732 | 0.030 |
Why?
|
Manometry | 1 | 2017 | 454 | 0.030 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 2 | 2009 | 3204 | 0.030 |
Why?
|
Incidental Findings | 1 | 2019 | 697 | 0.030 |
Why?
|
Models, Economic | 1 | 2018 | 716 | 0.030 |
Why?
|
Cisplatin | 2 | 2016 | 1652 | 0.030 |
Why?
|
Young Adult | 7 | 2019 | 59255 | 0.030 |
Why?
|
Carcinoma | 1 | 2005 | 2330 | 0.030 |
Why?
|
Survivors | 1 | 2004 | 2371 | 0.030 |
Why?
|
Nausea | 1 | 2016 | 679 | 0.030 |
Why?
|
Tissue Engineering | 1 | 2003 | 1868 | 0.030 |
Why?
|
Cost Savings | 1 | 2018 | 913 | 0.030 |
Why?
|
Anticoagulants | 1 | 2009 | 4812 | 0.030 |
Why?
|
Proportional Hazards Models | 2 | 2019 | 12463 | 0.030 |
Why?
|
Camptothecin | 1 | 2016 | 591 | 0.030 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 1993 | 817 | 0.030 |
Why?
|
Dimethylhydrazines | 2 | 1989 | 12 | 0.030 |
Why?
|
Dilatation | 1 | 1993 | 306 | 0.020 |
Why?
|
Equipment Failure | 1 | 1994 | 578 | 0.020 |
Why?
|
Carbon Dioxide | 1 | 1996 | 1147 | 0.020 |
Why?
|
Cardia | 1 | 2011 | 60 | 0.020 |
Why?
|
Gene Expression Regulation, Viral | 1 | 1993 | 439 | 0.020 |
Why?
|
Injections, Subcutaneous | 1 | 2012 | 681 | 0.020 |
Why?
|
Pulmonary Embolism | 1 | 2024 | 2567 | 0.020 |
Why?
|
Factor Analysis, Statistical | 1 | 2012 | 999 | 0.020 |
Why?
|
Pain | 1 | 2005 | 5073 | 0.020 |
Why?
|
Methylhydrazines | 1 | 1989 | 6 | 0.020 |
Why?
|
Nitrosamines | 2 | 1987 | 87 | 0.020 |
Why?
|
Tissue Array Analysis | 1 | 2011 | 550 | 0.020 |
Why?
|
Colitis | 2 | 1989 | 1233 | 0.020 |
Why?
|
Leadership | 1 | 2018 | 1385 | 0.020 |
Why?
|
Age Factors | 3 | 2013 | 18398 | 0.020 |
Why?
|
Predictive Value of Tests | 2 | 2019 | 15266 | 0.020 |
Why?
|
Quality Indicators, Health Care | 1 | 2018 | 1792 | 0.020 |
Why?
|
Administration, Oral | 1 | 2016 | 4021 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2016 | 4853 | 0.020 |
Why?
|
Carcinoma, Large Cell | 1 | 2008 | 113 | 0.020 |
Why?
|
Myocardial Infarction | 1 | 2009 | 11461 | 0.020 |
Why?
|
Transsexualism | 1 | 2012 | 208 | 0.020 |
Why?
|
Esophagitis, Peptic | 1 | 2008 | 76 | 0.020 |
Why?
|
In Situ Hybridization | 1 | 2011 | 1900 | 0.020 |
Why?
|
Vital Capacity | 1 | 2010 | 971 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2015 | 6228 | 0.020 |
Why?
|
Enhancer Elements, Genetic | 1 | 1993 | 1363 | 0.020 |
Why?
|
Hospitals | 1 | 2020 | 3882 | 0.020 |
Why?
|
Promoter Regions, Genetic | 2 | 1999 | 5790 | 0.020 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2011 | 610 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2024 | 22176 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2019 | 3600 | 0.020 |
Why?
|
Carcinoma, Small Cell | 1 | 2008 | 420 | 0.020 |
Why?
|
Spirometry | 1 | 2009 | 929 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2012 | 2850 | 0.020 |
Why?
|
Vascular Patency | 1 | 2009 | 911 | 0.020 |
Why?
|
Chylothorax | 1 | 2006 | 83 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2019 | 3877 | 0.020 |
Why?
|
Diagnostic Tests, Routine | 1 | 2011 | 787 | 0.020 |
Why?
|
Colonic Neoplasms | 2 | 1989 | 2538 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2012 | 3416 | 0.020 |
Why?
|
Cost-Benefit Analysis | 1 | 2018 | 5492 | 0.020 |
Why?
|
Polypropylenes | 1 | 2005 | 63 | 0.020 |
Why?
|
HIV Infections | 1 | 2012 | 17352 | 0.020 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2011 | 1092 | 0.020 |
Why?
|
Epidemiologic Methods | 1 | 2010 | 1336 | 0.020 |
Why?
|
Gastroscopy | 1 | 2006 | 211 | 0.020 |
Why?
|
Sutures | 1 | 1987 | 284 | 0.020 |
Why?
|
Granulation Tissue | 1 | 2004 | 92 | 0.020 |
Why?
|
ROC Curve | 1 | 2012 | 3579 | 0.020 |
Why?
|
Infant | 2 | 2019 | 36192 | 0.010 |
Why?
|
Precancerous Conditions | 1 | 2011 | 980 | 0.010 |
Why?
|
Perioperative Care | 1 | 2012 | 1036 | 0.010 |
Why?
|
Glucocorticoids | 1 | 1993 | 2161 | 0.010 |
Why?
|
Sex Factors | 2 | 2008 | 10553 | 0.010 |
Why?
|
Netherlands | 1 | 2008 | 2221 | 0.010 |
Why?
|
Genes, Reporter | 2 | 1999 | 1529 | 0.010 |
Why?
|
Laminectomy | 1 | 2003 | 225 | 0.010 |
Why?
|
Pancreatic Neoplasms | 3 | 1999 | 5369 | 0.010 |
Why?
|
Renal Insufficiency | 1 | 2008 | 809 | 0.010 |
Why?
|
Smoking | 2 | 2010 | 9053 | 0.010 |
Why?
|
Graft Survival | 1 | 1992 | 3820 | 0.010 |
Why?
|
Vitamin E | 1 | 1986 | 872 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2011 | 6075 | 0.010 |
Why?
|
Rats, Inbred Lew | 1 | 2003 | 1157 | 0.010 |
Why?
|
Drainage | 1 | 2006 | 1157 | 0.010 |
Why?
|
Mice, Transgenic | 3 | 1999 | 9541 | 0.010 |
Why?
|
Transfection | 2 | 1999 | 5774 | 0.010 |
Why?
|
Gastric Mucosa | 1 | 2003 | 604 | 0.010 |
Why?
|
Carcinoma, Transitional Cell | 1 | 1987 | 783 | 0.010 |
Why?
|
Vimentin | 1 | 2001 | 255 | 0.010 |
Why?
|
Molecular Targeted Therapy | 1 | 2011 | 2811 | 0.010 |
Why?
|
Intestinal Mucosa | 1 | 2011 | 3032 | 0.010 |
Why?
|
Regression Analysis | 1 | 2009 | 6344 | 0.010 |
Why?
|
Iontophoresis | 1 | 1999 | 74 | 0.010 |
Why?
|
Autopsy | 1 | 2003 | 1009 | 0.010 |
Why?
|
Blood Vessel Prosthesis Implantation | 1 | 2009 | 1428 | 0.010 |
Why?
|
Fluoroscopy | 1 | 2003 | 947 | 0.010 |
Why?
|
Boston | 1 | 2012 | 9326 | 0.010 |
Why?
|
Antigens, CD34 | 1 | 2001 | 658 | 0.010 |
Why?
|
Frozen Sections | 1 | 1999 | 153 | 0.010 |
Why?
|
1,2-Dimethylhydrazine | 2 | 1989 | 8 | 0.010 |
Why?
|
Mice, Inbred DBA | 1 | 1999 | 621 | 0.010 |
Why?
|
Transforming Growth Factor alpha | 1 | 1998 | 135 | 0.010 |
Why?
|
Models, Cardiovascular | 1 | 2003 | 981 | 0.010 |
Why?
|
Transcription Factor AP-1 | 1 | 1999 | 321 | 0.010 |
Why?
|
Receptor, erbB-3 | 1 | 1998 | 143 | 0.010 |
Why?
|
Biocompatible Materials | 1 | 2005 | 1685 | 0.010 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2003 | 1492 | 0.010 |
Why?
|
Mesocricetus | 2 | 1987 | 252 | 0.010 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 1998 | 412 | 0.010 |
Why?
|
Diagnostic Imaging | 1 | 2010 | 3530 | 0.010 |
Why?
|
Ventilation-Perfusion Ratio | 1 | 1996 | 117 | 0.010 |
Why?
|
Gene Expression | 2 | 1999 | 7581 | 0.010 |
Why?
|
Actins | 1 | 2003 | 2050 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2006 | 5247 | 0.010 |
Why?
|
Mitosis | 1 | 2001 | 1188 | 0.010 |
Why?
|
Transgenes | 1 | 1999 | 1010 | 0.010 |
Why?
|
Neutropenia | 1 | 2001 | 885 | 0.010 |
Why?
|
Liposomes | 1 | 1999 | 784 | 0.010 |
Why?
|
Graft Rejection | 1 | 2008 | 4446 | 0.010 |
Why?
|
Disease Progression | 1 | 2012 | 13510 | 0.010 |
Why?
|
Drug Carriers | 1 | 1999 | 706 | 0.010 |
Why?
|
Urinary Bladder Neoplasms | 1 | 1987 | 2223 | 0.010 |
Why?
|
HIV-1 | 1 | 2012 | 6863 | 0.010 |
Why?
|
Fluorescent Antibody Technique | 1 | 1998 | 2468 | 0.010 |
Why?
|
Models, Statistical | 1 | 2008 | 5079 | 0.010 |
Why?
|
Comorbidity | 1 | 2008 | 10508 | 0.010 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2008 | 3415 | 0.010 |
Why?
|
Wound Healing | 1 | 2004 | 2805 | 0.010 |
Why?
|
Animals | 9 | 2003 | 168467 | 0.010 |
Why?
|
Restriction Mapping | 1 | 1993 | 851 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-jun | 1 | 1993 | 287 | 0.010 |
Why?
|
Cricetinae | 2 | 1987 | 2423 | 0.010 |
Why?
|
Neurosurgical Procedures | 1 | 2003 | 2072 | 0.010 |
Why?
|
Mice | 6 | 1999 | 81533 | 0.010 |
Why?
|
Cell Nucleus | 1 | 2001 | 2910 | 0.010 |
Why?
|
Reference Values | 1 | 1999 | 4920 | 0.010 |
Why?
|
Receptors, Glucocorticoid | 1 | 1993 | 305 | 0.010 |
Why?
|
Dexamethasone | 1 | 1999 | 1948 | 0.010 |
Why?
|
Ligands | 1 | 1998 | 3272 | 0.010 |
Why?
|
Algorithms | 1 | 2010 | 14032 | 0.010 |
Why?
|
Genetic Vectors | 1 | 1998 | 3396 | 0.000 |
Why?
|
Recombinant Proteins | 1 | 1998 | 6534 | 0.000 |
Why?
|
Animals, Newborn | 1 | 1993 | 2677 | 0.000 |
Why?
|
FANFT | 1 | 1987 | 1 | 0.000 |
Why?
|
Receptor, erbB-2 | 1 | 1998 | 2557 | 0.000 |
Why?
|
Epithelial Cells | 1 | 1999 | 3677 | 0.000 |
Why?
|
Rats | 1 | 2003 | 23741 | 0.000 |
Why?
|
Phosphorylation | 1 | 1998 | 8321 | 0.000 |
Why?
|
Mutation | 1 | 2011 | 30054 | 0.000 |
Why?
|
Cystitis | 1 | 1987 | 95 | 0.000 |
Why?
|
Dose-Response Relationship, Drug | 1 | 1998 | 10766 | 0.000 |
Why?
|
Receptors, Platelet-Derived Growth Factor | 1 | 1986 | 178 | 0.000 |
Why?
|
Free Radicals | 1 | 1986 | 238 | 0.000 |
Why?
|
Acetylcysteine | 1 | 1987 | 260 | 0.000 |
Why?
|
Proto-Oncogene Proteins | 1 | 1998 | 4513 | 0.000 |
Why?
|
Cell Line | 1 | 1998 | 15601 | 0.000 |
Why?
|
Disease Models, Animal | 1 | 2003 | 18253 | 0.000 |
Why?
|
Mice, Inbred Strains | 1 | 1986 | 1762 | 0.000 |
Why?
|
Base Sequence | 1 | 1993 | 12441 | 0.000 |
Why?
|
Molecular Sequence Data | 1 | 1993 | 17635 | 0.000 |
Why?
|
Mice, Inbred C57BL | 1 | 1999 | 22172 | 0.000 |
Why?
|
Oncogenes | 1 | 1986 | 1222 | 0.000 |
Why?
|
Skin | 1 | 1993 | 4484 | 0.000 |
Why?
|
Cell Division | 1 | 1986 | 4465 | 0.000 |
Why?
|
Receptors, Cell Surface | 1 | 1986 | 2822 | 0.000 |
Why?
|
Body Weight | 1 | 1986 | 4618 | 0.000 |
Why?
|
Quality of Life | 1 | 1996 | 13367 | 0.000 |
Why?
|
Diet | 1 | 1986 | 8075 | 0.000 |
Why?
|